Skip to main content

Advertisement

Log in

Gastrointestinal stromal tumor of the stomach with extremely slow-growing hematogenous metastasis

  • Case Report
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

A 67-year-old woman underwent resection of a gastric tumor and a synchronous metastatic lesion of the liver in 1991. Histopathologically, both the primary and metastatic tumors were diagnosed as leiomyosarcoma. Four years after the initial resection, another liver metastasis was detected in the caudate lobe, and a partial hepatectomy was performed. Multiple bilateral lung metastases were identified 7 years later and one was resected. Immunohistochemically, tissues from both the primary and metastatic sites were positive for KIT and CD34, and a c-kit gene mutation was found in the resected lung lesion. The remaining lung metastases responded to treatment with imatinib mesylate, but the treatment was discontinued because of toxicity. The patient remains under observation and the lung lesions have not progressed. At present she has no symptoms, and she has had no further recurrences in the past 3 years. This case is extremely unusual; a slowly progressing gastrointestinal stromal tumor over the course of 17 years from the initial diagnosis, with hematogenous metastases at multiple sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DeMatteo RP, Lewis JJ, Leung D, et al. (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58

    Article  PubMed  CAS  Google Scholar 

  2. Hanau CA, Miettinen M (1995) Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 26:440–449

    Article  PubMed  CAS  Google Scholar 

  3. Singer S, Rubin BP, Lux ML, et al. (2002) Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20:3898–3905

    Article  PubMed  CAS  Google Scholar 

  4. Yamaguchi U, Hasegawa T, Sakurai S, et al. (2006) Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 14: 46–51

    Article  PubMed  Google Scholar 

  5. Demetri GD, Benjamin RS, Blanke CD, et al. (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5(Suppl 2):S1–29

    PubMed  Google Scholar 

  6. Blay JY, Bonvalot S, Casali P, et al. (2005) GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol 16:566–578

    Article  PubMed  Google Scholar 

  7. Kubota T (2006) Gastrointestinal stromal tumor (GIST) and imatinib. Int J Clin Oncol 11:184–189

    Article  PubMed  CAS  Google Scholar 

  8. Mudan SS, Conlon KC, Woodruff JM, et al. (2000) Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection. Cancer 88:66–74

    Article  PubMed  CAS  Google Scholar 

  9. Ballarini C, Intra M, Ceretti AP, et al. (1998) Gastrointestinal stromal tumors: a “benign” tumor with hepatic metastasis after 11 years. Tumori 84:78–81

    PubMed  CAS  Google Scholar 

  10. Matsuoka L, Stapfer M, Mateo R, et al. (2007) Left extended hepatectomy for a metastatic gastrointestinal stromal tumor after a disease-free interval of 17 years: report of a case. Surg Today 37:70–73

    Article  PubMed  Google Scholar 

  11. Inage Y, Yamabe K, Yamamoto T, et al. (2002) Resection for pulmonary metastasis of gastrointestinal stromal tumor of the stomach at 10 years after gastrectomy; report of a case (in Japanese). Kyobu Geka 55:907–911

    PubMed  CAS  Google Scholar 

  12. Raut CP, Posner M, Desai J, et al. (2006) Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 24:2325–2331

    Article  PubMed  CAS  Google Scholar 

  13. Van Glabbeke M, Verweij J, Casali PG, et al. (2005) Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study. J Clin Oncol 23:5795–5804

    Article  PubMed  Google Scholar 

  14. Blay JY, Le Cesne A, Ray-Coquard I, et al. (2007) Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group J Clin Oncol 25:1107–1113

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshinori Hosoya.

About this article

Cite this article

Kurashina, K., Hosoya, Y., Sakurai, S. et al. Gastrointestinal stromal tumor of the stomach with extremely slow-growing hematogenous metastasis. Int J Clin Oncol 14, 262–265 (2009). https://doi.org/10.1007/s10147-008-0834-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-008-0834-7

Key words

Navigation